Postpartum cardiomyopathy: A cardiac emergency for gynecologists general practitioners, internists, pulmonologists, and cardiologists;Die postpartale kardiomyopathie: Ein kardiologischer notfall für gynäkologen, hausärzte, internisten, pneumologen und kardiologen

Deutsches Arzteblatt

Volumn 105, Issue 44, 2008, Pages 751-756

  Hilfiker Kleiner, Denise ^a   Schieffer, Elisabeth ^a   Meyer, Gerd Peter ^a   Podewski, Edith ^a   Drexler, Helmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cardiomyopathy; Diagnosis; Heart failure; Postpartum disorder; Pregnancy

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CARVEDILOL; CATHEPSIN D; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN; MANGANESE SUPEROXIDE DISMUTASE; PENTOXIFYLLINE; PROLACTIN; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

CONGESTIVE CARDIOMYOPATHY; COUGHING; CYTOKINE RELEASE; DYSPNEA; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EMERGENCY; FEMALE; HEART FAILURE; HEMOSTASIS; HUMAN; INCIDENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PERIPARTUM CARDIOMYOPATHY; POSTPARTUM CARDIOMYOPATHY; PROGNOSIS; PROLACTIN RELEASE; PROLACTINOMA; PUERPERIUM; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; THIRD TRIMESTER PREGNANCY;

EID: 56449114081     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2008.0751     Document Type: Review

References (13)

1. Bozkurt B, Villaneuva FS, Holubkov R et al.: Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999; 34: 177-80.
2. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050-5.
3. Fett JD, Christie LG, Carraway RD, Murphy JG: Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005; 80: 1602-6.
4. Franchini M: Haemostasis and pregnancy. Thromb Haemost 2006; 95: 401-13.
5. Hilfiker-Kleiner D, Kaminski K, Podewski E et al.: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007; 128: 589-600.
6. Hilfiker-Kleiner D, Meyer GP, Schieffer E et al.: Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 2007; 50: 2354-5.
7. Imran SA, Ur E, Clarke DB: Managing prolactin-secreting adenomas during pregnancy. Canadian Family Physician 2007; 53: 653-8.
8. Sliwa K, Fett J, Elkayam U: Peripartum cardiomyopathy. Lancet 2006; 368: 687-93.
9. Sliwa K, Forster O, Libhaber E et al.: Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441-6.
10. Sliwa K, Norton GR, Kone N et al.: Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. J Am Coll Cardiol 2004; 44: 1825-30.
11. Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P: The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002; 4: 305-9.
12. Stepan H,Walther T, Pfeiffer D: Peripartum cardiomyopathy - the (un)known obstetrical cardiologic emergency situation. Z Kardiol 2003; 92: 811-6.
13. Witlin AG, Mattar F, Sibai BM: Postpartum stroke: a twenty-year experience. Am J Obstet Gynecol 2000; 183: 83-8.